Cargando…
Complement dysregulation is associated with severe COVID-19 illness
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) may manifest as thrombosis, stroke, renal failure, myocardial infarction, and thrombocytopenia, reminiscent of other complement- mediated diseases. Multiple clinical and preclinical studies have implicated complement in the pathogenesis of...
Autores principales: | Yu, Jia, Gerber, Gloria F., Chen, Hang, Yuan, Xuan, Chaturvedi, Shruti, Braunstein, Evan M., Brodsky, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052917/ https://www.ncbi.nlm.nih.gov/pubmed/34289657 http://dx.doi.org/10.3324/haematol.2021.279155 |
Ejemplares similares
-
COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria
por: Gerber, Gloria F., et al.
Publicado: (2021) -
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
por: Yu, Jia, et al.
Publicado: (2020) -
Evaluating complement dysregulation in livedoid vasculopathy using a functional assay
por: Eswaran, Harish, et al.
Publicado: (2023) -
Complement in the Pathophysiology of the Antiphospholipid Syndrome
por: Chaturvedi, Shruti, et al.
Publicado: (2019) -
C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
por: Shah, Hridaya, et al.
Publicado: (2022)